habener glp-1 TIME100 Health: Joel Habener, Dan Drucker, Svetlana Mojsov and Jens Juul Holst HMS Professor Wins Prestigious Lasker-DeBakey

Lucan M: Surgical treatment of Peyronie's disease (experience with excision and synthetic graft insertion)

Taking it along with diet and exercise helps control blood sugar levels

Our 2030 estimates contemplate global penetration into the addressable type 2 diabetes and obesity markets of only 8% and 2%, respectively (from about 3% and 0.2% in 2023). Uptake would likely be greater if these drugs could be consumed in oral form rather than injected, adds the report, An oral weight loss agent would likely be well-received in the primary care setting and could alleviate pressure on supply chains

Helaas mogen wij door de strenge EU-wetgeving maar beperkt informatie geven over de werking van producten